1. 2020
  2. Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

    Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Breckpot, K., Lecocq, Q., Lahoutte, T., Windhorst, A. D., Van Der Aa, F., Morgenstern, A., Bruchertseifer, F., Devoogdt, N. & D'Huyvetter, M., 21 Apr 2020, In : Cancers. 12, 4, 1017.

    Research output: Contribution to journalArticle

  3. Preclinical Targeted alpha- and beta(-)-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

    Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Windhorst, A. D., van der Aa, F., Lecocq, Q., Breckpot, K., Morgenstern, A., Bruchertseifer, F., Lahoutte, T., Devoogdt, N. & D'Huyvetter, M., Apr 2020, In : Cancers. 12, 4, 1017.

    Research output: Contribution to journalArticle

  4. Nanobody-mediated imaging of PD-L1 provides a rationale to combine Galsome vaccination with immune checkpoint blockade

    Ertveldt, T., Meulewaeter, S., Lentacker, I., Verbeke, R., De Smedt, S., Olarte, O., Barbé, K., Keyaerts, M., Dewitte, H. & Breckpot, K., 7 Feb 2020, p. 1. 1 p.

    Research output: Unpublished contribution to conferencePoster

  5. The impact of optimized mRNA on cancer vaccination

    De Mey, W., Lecocq, Q., Autaers, D., Breckpot, K., Thielemans, K. & Franceschini, L., 7 Feb 2020, (Unpublished).

    Research output: Unpublished contribution to conferencePoster

  6. The development of methods to detect the different hallmarks of immunogenic cell death

    De Munck, J., Kalus, P., Smets, H., Breckpot, K. & Aerts, J., 2020.

    Research output: Unpublished contribution to conferenceUnpublished abstract

  7. 2019
  8. Development of LAG-3 nanobodies as potent cancer imaging tracers

    Lecocq, Q., Awad, R. M., Zeven, K., De Vlaeminck, Y., de Mey, W., Debie, P., Puttemans, J., Goyvaerts, C., Raes, G., Keyaerts, M., Devoogdt, N. & Breckpot, K., Dec 2019, In : Annals of Oncology. 30

    Research output: Contribution to journalMeeting abstract (Journal)

  9. Theranostics in immuno-oncology using nanobody derivatives

    Lecocq, Q., De Vlaeminck, Y., Hanssens, H., D'Huyvetter, M., Raes, G., Goyvaerts, C., Keyaerts, M., Devoogdt, N. & Breckpot, K., 25 Oct 2019, In : Theranostics. 9, 25, p. 7772-7791 20 p., 10.7150/thno.34941.

    Research output: Contribution to journalScientific review

Previous 1 2 3 4 5 6 7 8 ...28 Next

ID: 182148